Literature DB >> 31913126

STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.

Jong Wook Kim1,2,3,4, Christian Berrios2,5, Miju Kim1,2, Amy E Schade2,5, Guillaume Adelmant6,7,8, Huwate Yeerna3, Emily Damato1, Amanda Balboni Iniguez1,9, Laurence Florens10, Michael P Washburn10,11, Kim Stegmaier1,9, Nathanael S Gray6, Pablo Tamayo3,4, Ole Gjoerup2, Jarrod A Marto6,7,8, James DeCaprio2,5,12, William C Hahn1,2,12.   

Abstract

Alterations involving serine-threonine phosphatase PP2A subunits occur in a range of human cancers, and partial loss of PP2A function contributes to cell transformation. Displacement of regulatory B subunits by the SV40 Small T antigen (ST) or mutation/deletion of PP2A subunits alters the abundance and types of PP2A complexes in cells, leading to transformation. Here, we show that ST not only displaces common PP2A B subunits but also promotes A-C subunit interactions with alternative B subunits (B''', striatins) that are components of the Striatin-interacting phosphatase and kinase (STRIPAK) complex. We found that STRN4, a member of STRIPAK, is associated with ST and is required for ST-PP2A-induced cell transformation. ST recruitment of STRIPAK facilitates PP2A-mediated dephosphorylation of MAP4K4 and induces cell transformation through the activation of the Hippo pathway effector YAP1. These observations identify an unanticipated role of MAP4K4 in transformation and show that the STRIPAK complex regulates PP2A specificity and activity.
© 2020, Kim et al.

Entities:  

Keywords:  MAP4K4; PP2A; STRIPAK; cancer biology; human; small t; transformation

Mesh:

Substances:

Year:  2020        PMID: 31913126      PMCID: PMC6984821          DOI: 10.7554/eLife.53003

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  84 in total

1.  Optimized large-scale production of high titer lentivirus vector pseudotypes.

Authors:  Miguel Sena-Esteves; Jessica C Tebbets; Sabine Steffens; Timothy Crombleholme; Alan W Flake
Journal:  J Virol Methods       Date:  2004-12-15       Impact factor: 2.014

2.  A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK.

Authors:  Xiaodong Feng; Nadia Arang; Damiano Cosimo Rigiracciolo; Joo Sang Lee; Huwate Yeerna; Zhiyong Wang; Simone Lubrano; Ayush Kishore; Jonathan A Pachter; Gabriele M König; Marcello Maggiolini; Evi Kostenis; David D Schlaepfer; Pablo Tamayo; Qianming Chen; Eytan Ruppin; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2019-02-14       Impact factor: 31.743

3.  Defining a Cancer Dependency Map.

Authors:  Aviad Tsherniak; Francisca Vazquez; Phil G Montgomery; Barbara A Weir; Gregory Kryukov; Glenn S Cowley; Stanley Gill; William F Harrington; Sasha Pantel; John M Krill-Burger; Robin M Meyers; Levi Ali; Amy Goodale; Yenarae Lee; Guozhi Jiang; Jessica Hsiao; William F J Gerath; Sara Howell; Erin Merkel; Mahmoud Ghandi; Levi A Garraway; David E Root; Todd R Golub; Jesse S Boehm; William C Hahn
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  A Conserved Motif Provides Binding Specificity to the PP2A-B56 Phosphatase.

Authors:  Emil Peter Thrane Hertz; Thomas Kruse; Norman E Davey; Blanca López-Méndez; Jón Otti Sigurðsson; Guillermo Montoya; Jesper V Olsen; Jakob Nilsson
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

5.  Control of protein phosphatase 2A by simian virus 40 small-t antigen.

Authors:  S I Yang; R L Lickteig; R Estes; K Rundell; G Walter; M C Mumby
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

Authors:  C M Counter; W C Hahn; W Wei; S D Caddle; R L Beijersbergen; P M Lansdorp; J M Sedivy; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene.

Authors:  Hung Thanh Nguyen; Xin Hong; Sam Tan; Qingfeng Chen; Lifang Chan; Marc Fivaz; Stephen M Cohen; P Mathijs Voorhoeve
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

8.  Structural probing of a protein phosphatase 2A network by chemical cross-linking and mass spectrometry.

Authors:  Franz Herzog; Abdullah Kahraman; Daniel Boehringer; Raymond Mak; Andreas Bracher; Thomas Walzthoeni; Alexander Leitner; Martin Beck; Franz-Ulrich Hartl; Nenad Ban; Lars Malmström; Ruedi Aebersold
Journal:  Science       Date:  2012-09-14       Impact factor: 47.728

9.  Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.

Authors:  Yi-Chun Kuo; Kai-Yun Huang; Chung-Hsiang Yang; Yu-San Yang; Wen-Yu Lee; Chi-Wu Chiang
Journal:  J Biol Chem       Date:  2007-11-27       Impact factor: 5.157

Review 10.  MAP4K4: an emerging therapeutic target in cancer.

Authors:  Xuan Gao; Chenxi Gao; Guoxiang Liu; Jing Hu
Journal:  Cell Biosci       Date:  2016-10-28       Impact factor: 7.133

View more
  12 in total

1.  KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.

Authors:  Sudeep Banerjee; Hyunho Yoon; Stephanie Ting; Chih-Min Tang; Mayra Yebra; Alexander T Wenzel; Huwate Yeerna; Jill P Mesirov; Robert J Wechsler-Reya; Pablo Tamayo; Jason K Sicklick
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.261

2.  Strip1 regulates retinal ganglion cell survival by suppressing Jun-mediated apoptosis to promote retinal neural circuit formation.

Authors:  Mai Ahmed; Yutaka Kojima; Ichiro Masai
Journal:  Elife       Date:  2022-03-22       Impact factor: 8.140

3.  CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress.

Authors:  Feng Li; David Kozono; Peter Deraska; Timothy Branigan; Connor Dunn; Xiao-Feng Zheng; Kalindi Parmar; Huy Nguyen; James DeCaprio; Geoffrey I Shapiro; Dipanjan Chowdhury; Alan D D'Andrea
Journal:  Mol Cell       Date:  2020-10-26       Impact factor: 17.970

Review 4.  Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.

Authors:  Yong Suk Cho; Jin Jiang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 5.  Regulation of MST complexes and activity via SARAH domain modifications.

Authors:  Sofiia Karchugina; Dorothy Benton; Jonathan Chernoff
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 4.919

6.  Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers.

Authors:  Liwei An; Zhifa Cao; Pingping Nie; Hui Zhang; Zhenzhu Tong; Fan Chen; Yang Tang; Yi Han; Wenjia Wang; Zhangting Zhao; Qingya Zhao; Yuqin Yang; Yuanzhi Xu; Gemin Fang; Lei Shi; Huixiong Xu; Haiqing Ma; Shi Jiao; Zhaocai Zhou
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

7.  MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.

Authors:  Stephen J Fuller; Nick S Edmunds; Liam J McGuffin; Michelle A Hardyman; Joshua J Cull; Hajed O Alharbi; Daniel N Meijles; Peter H Sugden; Angela Clerk
Journal:  Biochem J       Date:  2021-06-11       Impact factor: 3.857

8.  WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.

Authors:  Sanghoon Lee; John Jun; William J Kim; Pablo Tamayo; Stephen B Howell
Journal:  Anticancer Res       Date:  2020-11       Impact factor: 2.435

9.  STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity.

Authors:  Camille Valérie De Jamblinne; Barbara Decelle; Mehrnoush Dehghani; Mathieu Joseph; Neera Sriskandarajah; Kévin Leguay; Basile Rambaud; Sébastien Lemieux; Philippe P Roux; David R Hipfner; Sébastien Carréno
Journal:  J Cell Biol       Date:  2020-11-02       Impact factor: 10.539

Review 10.  Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome.

Authors:  Mona M Ahmed; Camille H Cushman; James A DeCaprio
Journal:  Viruses       Date:  2021-12-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.